hotspot -WSS

hotspot

author：explore 2025-09-07 21:56:48 - browse：16917

Pfizer plans to exit a major biotechnology industry trade association. Cindy Ord/Getty Images for Pfizer/BioNTech

WASHINGTON — Pfizer has decided to leave the Biotechnology Innovation Organization, according to two sources familiar with the planning.

The departure is a blow to BIO, which represents members ranging from small biotech startups to massive pharmaceutical companies. The group on Tuesday announced its new CEO, rare disease advocate and biotech executive John Crowley.

“The economic situation for the industry is difficult indeed and we of course are disappointed that any company would be forced to take a break from its BIO membership. We certainly hope that when economic conditions improve, we can welcome those companies back and welcome new members to join us as well, but it in no way affects our mission of protecting patients and medical innovation in the United States,” said BIO’s Chief Public Affairs and Marketing Officer Rich Masters. Masters said he wouldn’t comment on the status of any particular member.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Key Senate panel to consider PBM, drug pricing reform package

explore

WSS

The painfully weak evidence on taking collagen to treat arthritis

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Biden praises World Series champion Astros for impact off the field during White House celebration

Judge rejects Trump's counterclaim against E. Jean Carroll

After Sarepta trial failure, Duchenne families brace for more debate

Medicare proceeds with plan to claw back hospital funds

leisure time

hotspot

explore

Sports medicine is finally prioritizing gender equality

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

New air purifier tech could be key to improving indoor air quality

Inari Medical to buy amputation prevention company LimFlow

United colonoscopy coverage change 'may cost lives,' doctors say

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Medical leaders decry Supreme Court decision on affirmative action

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Tori Bowie and the unacceptable rates of Black maternal death

Bill would allow buprenorphine prescription for addiction via telehealth

explore

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Wegovy cuts risk of cardiovascular events by 20%, study finds

Prime Medicine says its gene editing passes test in monkeys

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

Infant mortality in U.S. rose last year for first time in decades: CDC

Zapping the brain for stroke rehab: Pivotal clinical trial begins

entertainment

explore

explore

Wikipedia